Identification of Bioactive Peptides from a Laminaria digitata Protein Hydrolysate Using In Silico and In Vitro Methods to Identify Angiotensin-1-Converting Enzyme (ACE-1) Inhibitory Peptides

Abstract

Bioactive peptides range in size from 2–30 amino acids and may be derived from any protein-containing biomass using hydrolysis, fermentation or high-pressure processing. Pro-peptides or cryptides result in shorter peptide sequences following digestion and may have enhanced bioactivity. Previously, we identified a protein hydrolysate generated from Laminaria digitata that inhibited ACE-1 in vitro and had an ACE-1 IC50 value of 590 µg/mL compared to an ACE-1 IC50 value of 500 µg/mL (~2.3 µM) observed for the anti-hypertensive drug Captopril©. A number of peptide sequences (130 in total) were identified using mass spectrometry from a 3 kDa permeate of this hydrolysate. Predicted bioactivities for these peptides were determined using an in silico strategy previously published by this group utilizing available databases including Expasy peptide cutter, BIOPEP and Peptide Ranker. Peptide sequences YIGNNPAKGGLF and IGNNPAKGGLF had Peptide Ranker scores of 0.81 and 0.80, respectively, and were chemically synthesized. Synthesized peptides were evaluated for ACE-1 inhibitory activity in vitro and were found to inhibit ACE-1 by 80 ± 8% and 91 ± 16%, respectively. The observed ACE-1 IC50 values for IGNNPAKGGLF and YIGNNPAKGGLF were determined as 174.4 µg/mL and 133.1 µg/mL. Both peptides produced sequences following simulated digestion with the potential to inhibit Dipeptidyl peptidase IV (DPP-IV).

Impact of Lactiplantibacillus plantarum and casein fortification on angiotensin converting enzyme inhibitory peptides in yogurt: identification and in silico analysis

“…PeptideCutter is used to cleave peptide sequences and determine enzyme cleavage sites, and the analysis can be used to predict peptide digestion products. 42 According to the data in Table 6, none of the 25 peptide sequences exhibited toxicity after prediction, and 12 sequences were non-allergenic after prediction.…”

Potential Impact of Bioactive Peptides from Foods in the Treatment of Hypertension

“…ACE-I in silico and in vitro [65] ACE-I, angiotensin-converting enzyme inhibitor; ALD, aldosterone; AGT, angiotensinogen; AT1-R, angiotensin-1 receptor; ET-1, endothelin-1; NO, nitric oxide.…”

Algae as a potential source of protein meat alternatives

“…There is no doubt about the promising future of the use of peptides from algae sources in human supplementation and the development of functional foods, but further research is needed to address the feasibility and safety implications to offer the consumer functional and affordable meat alternatives without demeriting the sensorial properties. In this context, the application of in silico methods and computational modeling becomes an invaluable approach to predicting potential bioactivities, which could save time and money, facilitating the supply of stable and quality peptides as an additive ( 83 , 112 ). Additionally, marine environment is a source of diverse compounds, affecting aquaculture industry then by the geographical, anthropogenic and seasonal factors.…”